Prognostic utility and characterization of left ventricular hypertrophy using global thickness
(2023) In Scientific Reports 13(1).- Abstract
Cardiovascular magnetic resonance (CMR) can accurately measure left ventricular (LV) mass, and several measures related to LV wall thickness exist. We hypothesized that prognosis can be used to select an optimal measure of wall thickness for characterizing LV hypertrophy. Subjects having undergone CMR were studied (cardiac patients, n = 2543; healthy volunteers, n = 100). A new measure, global wall thickness (GT, GTI if indexed to body surface area) was accurately calculated from LV mass and end-diastolic volume. Among patients with follow-up (n = 1575, median follow-up 5.4 years), the most predictive measure of death or hospitalization for heart failure was LV mass index (LVMI) (hazard ratio (HR)[95% confidence interval]... (More)
Cardiovascular magnetic resonance (CMR) can accurately measure left ventricular (LV) mass, and several measures related to LV wall thickness exist. We hypothesized that prognosis can be used to select an optimal measure of wall thickness for characterizing LV hypertrophy. Subjects having undergone CMR were studied (cardiac patients, n = 2543; healthy volunteers, n = 100). A new measure, global wall thickness (GT, GTI if indexed to body surface area) was accurately calculated from LV mass and end-diastolic volume. Among patients with follow-up (n = 1575, median follow-up 5.4 years), the most predictive measure of death or hospitalization for heart failure was LV mass index (LVMI) (hazard ratio (HR)[95% confidence interval] 1.16[1.12-1.20], p < 0.001), followed by GTI (HR 1.14[1.09-1.19], p < 0.001). Among patients with normal findings (n = 326, median follow-up 5.8 years), the most predictive measure was GT (HR 1.62[1.35-1.94], p < 0.001). GT and LVMI could characterize patients as having a normal LV mass and wall thickness, concentric remodeling, concentric hypertrophy, or eccentric hypertrophy, and the three abnormal groups had worse prognosis than the normal group (p < 0.05 for all). LV mass is highly prognostic when mass is elevated, but GT is easily and accurately calculated, and adds value and discrimination amongst those with normal LV mass (early disease).
(Less)
- author
- organization
-
- LTH Profile Area: Engineering Health
- Lund Cardiac MR Group (research group)
- eSSENCE: The e-Science Collaboration
- Arrhytmias and Cardiac Device treatment (research group)
- Molecular Cardiology (research group)
- Clinical studies af Atrial Fibrillation (research group)
- Electrocardiology Research Group - CIEL (research group)
- Emergency medicine (research group)
- Cardiovascular Research - Hypertension (research group)
- EpiHealth: Epidemiology for Health
- publishing date
- 2023-12-20
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Cardiology, Left ventricular hypertrophy
- in
- Scientific Reports
- volume
- 13
- issue
- 1
- article number
- 22806
- publisher
- Nature Publishing Group
- external identifiers
-
- scopus:85180193352
- pmid:38129418
- ISSN
- 2045-2322
- DOI
- 10.1038/s41598-023-48173-7
- language
- English
- LU publication?
- yes
- additional info
- © 2023. The Author(s).
- id
- abcda6b7-9866-452b-8183-4cb961f9e11a
- date added to LUP
- 2023-12-24 01:15:33
- date last changed
- 2024-11-02 03:54:23
@article{abcda6b7-9866-452b-8183-4cb961f9e11a, abstract = {{<p>Cardiovascular magnetic resonance (CMR) can accurately measure left ventricular (LV) mass, and several measures related to LV wall thickness exist. We hypothesized that prognosis can be used to select an optimal measure of wall thickness for characterizing LV hypertrophy. Subjects having undergone CMR were studied (cardiac patients, n = 2543; healthy volunteers, n = 100). A new measure, global wall thickness (GT, GTI if indexed to body surface area) was accurately calculated from LV mass and end-diastolic volume. Among patients with follow-up (n = 1575, median follow-up 5.4 years), the most predictive measure of death or hospitalization for heart failure was LV mass index (LVMI) (hazard ratio (HR)[95% confidence interval] 1.16[1.12-1.20], p < 0.001), followed by GTI (HR 1.14[1.09-1.19], p < 0.001). Among patients with normal findings (n = 326, median follow-up 5.8 years), the most predictive measure was GT (HR 1.62[1.35-1.94], p < 0.001). GT and LVMI could characterize patients as having a normal LV mass and wall thickness, concentric remodeling, concentric hypertrophy, or eccentric hypertrophy, and the three abnormal groups had worse prognosis than the normal group (p < 0.05 for all). LV mass is highly prognostic when mass is elevated, but GT is easily and accurately calculated, and adds value and discrimination amongst those with normal LV mass (early disease).</p>}}, author = {{Lundin, Magnus and Heiberg, Einar and Nordlund, David and Gyllenhammar, Tom and Steding-Ehrenborg, Katarina and Engblom, Henrik and Carlsson, Marcus and Atar, Dan and van der Pals, Jesper and Erlinge, David and Borgquist, Rasmus and Khoshnood, Ardavan and Ekelund, Ulf and Nickander, Jannike and Themudo, Raquel and Nordin, Sabrina and Kozor, Rebecca and Bhuva, Anish N and Moon, James C and Maret, Eva and Caidahl, Kenneth and Sigfridsson, Andreas and Sörensson, Peder and Schelbert, Erik B and Arheden, Håkan and Ugander, Martin}}, issn = {{2045-2322}}, keywords = {{Cardiology; Left ventricular hypertrophy}}, language = {{eng}}, month = {{12}}, number = {{1}}, publisher = {{Nature Publishing Group}}, series = {{Scientific Reports}}, title = {{Prognostic utility and characterization of left ventricular hypertrophy using global thickness}}, url = {{https://lup.lub.lu.se/search/files/167388409/s41598-023-48173-7.pdf}}, doi = {{10.1038/s41598-023-48173-7}}, volume = {{13}}, year = {{2023}}, }